文献速递肥胖与代谢综合征

握力与临床前肥胖进展轨迹:基于UK Biobank的多状态模型分析

Handgrip Strength and Trajectories of Preclinical Obesity Progression: A Multistate Model Analysis Using the UK Biobank.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

基于UK Biobank 93 275名参与者的多状态模型分析显示,握力每增加1个标准差,临床前肥胖各阶段进展风险显著降低,基线至首个功能障碍的完全校正HR为0.86(95%CI 0.85-0.88)。握力最高三分位相比最低三分位,在双功能障碍至全因死亡轨迹中保护效应最显著(完全校正HR 0.77,95%CI 0.70-0.84)。

要点

  • 握力每增1个SD,临床前肥胖各阶段进展风险显著降低。
  • 握力最高三分位者双功能障碍至全因死亡风险降低(HR 0.77)。
  • 改善肌肉量和力量对临床前肥胖管理具有潜在重要性。

核心结论

  • 握力增加与肥胖所致功能障碍进展及多因死亡风险降低显著相关。
  • 研究结果强调在临床前肥胖阶段改善肌肉量和力量的重要性。

研究设计与样本

  • 基于UK Biobank 93 275名参与者的多状态模型分析,平均随访13.4年。
  • 临床前肥胖定义为BMI升高合并腰围、腰臀比、腰高比或体脂百分比中至少1项异常,且无肥胖所致功能障碍。
  • 采用三个模型捕捉从基线至功能障碍和死亡的不同轨迹,含或不含中间进展。
  • 敏感性分析使用游离肌肉体积、总瘦体重和肌肉体重比作为暴露。

主要发现

  • 随访期间共发生8163例死亡事件。
  • 握力每增加1个SD,基线至首个功能障碍的完全校正HR为0.86(95%CI 0.85-0.88)。
  • 握力最高三分位相比最低三分位,双功能障碍至全因死亡的完全校正HR为0.77(95%CI 0.70-0.84)。
  • 亚组和敏感性分析结果一致。

临床怎么用

  • 在内分泌科临床前肥胖管理中,可考虑将握力作为肌肉力量评估指标。
  • 对临床前肥胖患者,改善肌肉量和力量可能有助于延缓功能障碍进展和降低死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Grip strength has been increasingly recognized as a predictor of chronic disease risk and mortality. The aim of our study was to investigate the association of grip strength and the trajectories of preclinical obesity progression. METHODS: Data were collected from 93 275 participants in the UK Biobank. Preclinical obesity was diagnosed based on an excess of anthropometric parameters, defined as elevated body mass index combined with at least 1 abnormal measure among waist circumference, waist-to-hip ratio, waist-to-height ratio, or percentage body fat, in the absence of obesity-induced dysfunctions. Three models captured different trajectories from baseline to dysfunctions and death, with or without intermediate progression. A multistate model was used to investigate the association between grip strength and the preclinical obesity progression and multiple-cause mortality risk. Sensitivity analyses were performed using free muscle volume, total lean mass, and muscle-to-weight ratio as exposures. RESULTS: Among 8163 death events over a mean follow-up of 13.4 years, each SD increase in grip strength was associated with a significantly reduced risk of preclinical obesity progression at each stage, with the strongest inverse association observed in baseline to first dysfunction [fully adjusted hazard ratio (HR): 0.86, 95% confidence interval (CI): 0.85-0.88]. Compared to the lowest tertile, the highest grip strength significantly showed protective effects across all trajectory models, with double dysfunctions to all-cause death yielding the most pronounced associations (fully adjusted HR: 0.77, 95% CI: 0.70-0.84). Further subgroup and sensitivity analysis showed consistent results. CONCLUSION: Increased grip strength was significantly associated with a decreased risk of obesity-induced dysfunctions progression and multiple-cause mortality. These findings underscore the importance of improving muscle mass and strength in preclinical obesity.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Xu M, Li M, Zhang Y, et al. Handgrip Strength and Trajectories of Preclinical Obesity Progression: A Multistate Model Analysis Using the UK Biobank. J Clin Endocrinol Metab. 2026. PMID: 41092288. doi:10.1210/clinem/dgaf521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。